Some of Our Network
Managing Director, Wound Market Consulting
More than 20 years' experience in bringing woundcare products to market across a range of European countries.
Experienced in start-ups and product development as well as in bringing mature products to new markets. Previous roles and experience include Regional Vice-President for ConvaTec for Scandinavia and Central & Eastern Europe; Managing Director of Insense Ltd (biotech and woundcare), non-executive director on medical device start-ups, fund-raising for new businesses.
Andrew is a lay member of the Tissue Viability Society, the European Wound Management Association, the Societe francaise et francophone des plaies et cicatrisations and the Deutsche Gesellschaft fuer Wundheilung und Wundmanagement.
Dr Benaka Karanth BAMS, M.Sc
Clinical Trial Administrator, Wound Market Consulting
Dr Karanth has a combination of academia and extensive experience within the Health Care and Clinical Research industries. He is a qualified physician in Ayurvedic System of Medicine and his interest in the field of new drug development led him to pursue post-graduation in Clinical Research from the Cranfield University, UK.
Dr Karanth has been actively involved in Clinical Research since 2008, specialising in Clinical Operations and Essential Documents Management. He has worked as a Clinical Research Associate for Reliance Life Sciences and Trial Master File specialist for Phlexglobal.
His key strengths include Clinical Trial designing and monitoring, Medical Writing, Clinical research management and Quality control of trial related documents.
Missing Quote details
Quote identifier code incorrect!
Wound Market Consulting's associates have backgrounds in major woundcare companies such as ConvaTec, KCi, Smith & Nephew, in technology-based start-ups and in regulatory and health provider organisations.
We continue to expand our network of associates and welcome approaches from anyone who can demonstrate a results-orientated track record in any field of the woundcare industry including the prevention of wounds.
Magda Esteve has over 20 years of global medical experience in marketing and sales management, new business development and implementation with multinational companies including Urgo in Spain.
For the past 14 years she has worked in the wound care products arena, where she has been responsible for marketing and product development in companies including MSD, Hartmann and Urgo. Currently she manages distribution of wound care & Epidermolysis Bullosa (EB) products across Spain.
Magda has a comprehensive understanding of global healthcare markets and commercial, regulatory and reimbursement opportunities and challenges. She is familiar with the primary Wound Societies in Spain as well as the 17 different Spanish health systems and is fluent in Spanish, English, French and conversational Italian.
Ferruccio Fiordispini, MBA
Ferruccio Fiordispini has more than 25 years business experience in marketing & general management across Europe, with multinationals including Nestle and Bristol-Myers Squibb.
For the past 10 years he has worked in the wound care industry, leading start-ups and product launches projects. His roles have included EMEA marketing director for ConvaTec and European managing director for Spiracur, a Californian medical device company focused on the development of innovative wound healing technologies.
His areas of expertise include international management, general management, marketing and human resources development, aided by a fluency in Italian, English and German.
Dr Michel Hermans
Dr Hermans trained in general surgery, trauma care and burn care in the Netherlands, at the University of Groningen and the Rode Kruis Ziekenhuis (Red Cross Hospital and Burn center), Beverwijk.
He joined the medical device industry as Medical Director International for ConvaTec in 1987, with responsibilities for clinical trials and medical marketing, as well as an advisory role for R&D. During this tenure with the company he regularly returned to the Beverwijk burn center and Euroskinbank to keep himself updated on burn care.
In 2004 he resigned from ConvaTec and became an independent consultant, focussing on medical, clinical and medical marketing consulting, primarily in the medical device and surgical industry fields and with wound and trauma care as a special area of interest.
He has given more than 450 lectures worldwide and has published more than 200 articles, posters and book chapters, primarily on basic research, clinical and health economic aspects of wound and burn care.
He sits on the industrial board of the ISBI and was the editor of a supplement to "Burns" and co editor of two more books on wound care and wound infections. He sits on the review boards of four wound care journals and is ad-hoc reviewer for a number of journals, including "Burns", "Biomedical Materials Research part B", "Applied Biomaterials" and the "American Journal of Infection Control".
Dr Jonathan Hughes, PH.D
Dr Hughes has 27 years of worldwide regulatory and clinical affairs experience across medical devices, combination products and human / veterinary pharmaceuticals.
Following completion of his PhD in veterinary pathophysiology, Jonathan began his career in regulatory affairs at A H Robins. He subsequently held regulatory affairs positions in drug and device companies, including Smith & Nephew, Glaxo, Bristol-Myers Squibb and ConvaTec. Jonathan has served on two European Commission Expert Working Groups on the Drug / Device Borderline and Device Classification. With 23 years of combined regulatory experience in wound care companies, Jonathan specialises in regulatory strategy, regulatory and clinical development pathways, worldwide regulatory submissions and training. He has worked with all the major international regulatory agencies, in particular US FDA, Japanese PMDA, Chinese FDA, Notified Bodies and EU Competent Authorities.
Jonathan is a Fellow of the regulatory professional organisation, TOPRA, and is a regular contributor on numerous educational and training programmes, delivering lectures and acting as advisor for two medical technology MSc courses (at the University of Hertfordshire and Cranfield University) and a MRes course with Newcastle University.
RNDr. Jiri Letal
Dr Letal is a Statistician with more than 28 years experience in biometrics, including 8 years in clinical trial statistical analysis and in excess of 20 years in biometrics research & lecturing.
He has worked at several international CROs and pharmaceutical companies including Advanced Drug and Device Services (France) and Novo Nordisk (Denmark), managing statistical analyses and reporting for clinical trials phase I-IV in a variety of therapeutic fields. He has been the principal statistician for more than 20 multicentric clinical projects and primary administrator for two analytical EuroConferences.
His strengths include SAS programming and statistical methodologies of generalized mixed models, linear and nonlinear regression analysis, survival analysis, categorical analysis, multivariate methods, FDA and ICH guidelines (including CDISC standards) and the design of data processing, programming and statistics SOPs. He is also a long standing member of the International Society of Clinical Biostatisticians (ISCB).
Michael McNally, MBA
Mike McNally has more than 30 years experience providing leadership in Business Development (Mergers & Acquisitions, Licensing, Divestitures), Operational Finance and Strategic Planning in the global medical device industry, with focus on wound care, ostomy and continence care.
He has an extensive and highly successful track record in all phases of corporate deal making including framing strategic direction, opportunity identification and screening, financial modeling and valuation, due diligence, deal structure and negotiations, and integration planning and execution.
His previous roles included VP, Business Development at ConvaTec and a number of financial leadership positions at ConvaTec, Bristol-Myers Squibb and Unisys. Mike holds an undergraduate degree in Mathematical Eonomics from Colgate University and an MBA from Seton Hall University.
Benjamin Vicuna, MBA
Benjamin Vicuna has more than 20 years of global medical experience in marketing and sales management, new business development and general business management with multinational companies including Johnson & Johnson, Boston Scientific and Healthpoint Biotherapeutics. Most recently he was General Manager for Latin America for Molnlycke Healthcare.
For the past 11 years he has worked in the wound care and surgical products arena where he was responsible for leading international expansion in Latin America and Europe of several new technologies. He brings a proven track record of successful identification and development of global market opportunities and a strong understanding of global healthcare markets and commercial, regulatory and reimbursement opportunities and challenges.
His areas of expertise include Latin America where he has developed strong business, distributor and clinical network over the years. He is fluent in Spanish and conversational Portuguese.
Barry Willemsteijn has more than 25 years clinical and business experience in woundcare across Europe. Having been Head nurse in surgical intensive care (University hospital Leiden, Netherlands), the founder and former President of the Dutch Wound Care Association (WCS) and holding Marketing and Sales positions at ConvaTec, Dermagenics Europe and Beese Medical.
His key strengths include product development (i.e. clinical testing; CE regulation - Post Market Surveillances) and business development (i.e. acquisition of distribution partners; marketing and sales planning; training skills) and an extensive network of key contacts in European woundcare associations and organisations.